e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
COPD exacerbation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Procalcitonin use in acute exacerbations of COPD
T. Medveczky, M. Jackson (Haywards Heath, United Kingdom)
Source:
Annual Congress 2011 - COPD exacerbation
Session:
COPD exacerbation
Session type:
Thematic Poster Session
Number:
563
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Medveczky, M. Jackson (Haywards Heath, United Kingdom). Procalcitonin use in acute exacerbations of COPD. Eur Respir J 2011; 38: Suppl. 55, 563
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017
Management of acute COPD exacerbations
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Acute management of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012
Acute exacerbations of COPD
Source: Eur Respir Monogr 2016; 74: 48-65
Year: 2016
Prognosis after hospitalization for acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
Source: Eur Respir Rev 2017; 26: 160073
Year: 2017
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
NIV in COPD: acute exacerbation and beyond
Source: ERS course 2015
Year: 2015
Our experience of procalcitonin assay in identifying bacterial COPD exacerbations
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Pollutant-induced acute exacerbations of asthma and COPD
Source: ERS Lung Science Conference 2019
Year: 2019
Is CRP a reliable diagnostic tool for infective exacerbations of COPD?
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept